Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb

NCT ID: NCT00212550

Last Updated: 2016-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obtain sputum smears within one day to rule out TB

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary TB

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TB diagnosis

Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.

Intervention Type PROCEDURE

Sputum induction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.

Sputum induction

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All subjects admitted to Bellevue Hospital for evaluation of possible TB

Exclusion Criteria

* Unable to produce spontaneous or induced sputum
Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rany Condos, MD

Role: PRINCIPAL_INVESTIGATOR

NYU School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NYU School of Medicine Division of Pulmonary and Critical Care

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9250-04B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sputum-free Diagnostis of TB
NCT07125274 RECRUITING
Plasma MTB cfDNA Before Bronchoscopy
NCT07230457 NOT_YET_RECRUITING